Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02328794 · ClinicalTrials.gov registry record · NA
Randomized Clinical Trial to Reduce Harm From Tobacco
A NA study of Smoking Cessation, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 6,006
- Enrollment target
- 1
- Study location
NCT02328794: Completed NA study of Smoking Cessation, sponsored by University of Pennsylvania.
NCT02328794 is a NA study of Smoking Cessation that has completed, run by University of Pennsylvania. The registered enrollment target is 6,006 participants, above the 443-participant average among 188 other Smoking Cessation trials with a reported enrollment target (1256% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02328794, a NA study of Smoking Cessation, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 6,006 participants
- Enrollment target
- 1
- Study location
Study Summary
Using the NIH-funded Way to Health platform, the investigators will conduct this smoking cessation RCT among Vitality/Discovery beneficiaries. The investigators will be able to determine the effectiveness of 4 different interventions aimed at smoking cessation, two of which are incentive structures that are each grounded in behavioral economic principles. The other interventions will determine the effectiveness of various cessation aids, including electronic cigarettes and text messaging, on smoking cessation. This study will be conducted as an opt-out procedure where participants are automatically enrolled in the program but have the choice to unenroll if they so chose. This pragmatic approach will allow us to investigate the effects of such programs in an employee based population that can be easily mimicked in other employee based populations.
Primary Outcome
Biometric testing (metabolites of nicotine) at 6 months following the quit date
Conditions Studied
Interventions
- BEHAVIORAL Control
- BEHAVIORAL E-cigarette free access
- BEHAVIORAL E-cigarette/NRT/Zyban/Chantix Choice
- BEHAVIORAL Outcome Incentive arm
- BEHAVIORAL Loss framing incentive arm
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,006 participants |
| Start Date | 2015-01-01 |
| Est. Completion | 2017-04-20 |
| Phase | NA |
What the finished NCT02328794 record still lists
NCT02328794 is an interventional study that assigns participants to a tested intervention. Its 6,006 participants enrollment target places it among the larger protocols in the corpus, above the 443-participant average among 188 other Smoking Cessation trials with a reported enrollment target (1256% higher).
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 5 interventions - of which Control is the first listed.
NCT02328794 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02328794 about?
NCT02328794 is a clinical study titled "Randomized Clinical Trial to Reduce Harm From Tobacco". Using the NIH-funded Way to Health platform, the investigators will conduct this smoking cessation RCT among Vitality/Discovery beneficiaries. The investigators will be able to determine the effectiveness of 4 different interventions aimed at smoking cessation, two of which are incentive structures ...
What is the current status of trial NCT02328794?
This trial is currently completed. It is a NA study. The enrollment target is 6,006 participants. The study started on 2015-01-01. Estimated completion is 2017-04-20.
What conditions does trial NCT02328794 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT02328794?
The interventions under investigation include: Control (BEHAVIORAL), E-cigarette free access (BEHAVIORAL), E-cigarette/NRT/Zyban/Chantix Choice (BEHAVIORAL), Outcome Incentive arm (BEHAVIORAL), Loss framing incentive arm (BEHAVIORAL).
Who is sponsoring clinical trial NCT02328794?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02328794 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02328794's enrollment target sits among peer trials
6,006 1st of 188 higher than 188 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00005095 · 6,000 participants
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
- NCT00280202 · 6,000 participants
Detection of Genetic Markers of Lung Cancer
- NCT03127631 · 6,000 participants · NA
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
- NCT03539705 · 6,000 participants
Food Allergy Registry at a Single Site
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI